Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change
26-10-08	€0.5540	0.00%
26-10-07	€0.5540	-3.48%
26-10-06	€0.5740	+2.14%
26-10-05	€0.5620	+1.81%
26-10-02	€0.5520	+16.21%

Delayed Quote Börse Stuttgart

More quotes

Market Closed - Börse Stuttgart 15:55:20 2026-10-08 EDT			5-day change	1st Jan Change
0.5540 ^EUR	0.00%		+9.06%	-34.36%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-29	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.22M 2.68M 2.44M 4.59M 312M 4.63M 32.21M 12.6M 159M 12.09M 11.83M 510M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.43M 3.69M 3.35M 6.31M 429M 6.37M 44.32M 17.33M 218M 16.64M 16.28M 701M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

Markets		Quality
Euronext Paris	ALKLA	Real-time
Deutsche Boerse AG	4YA	Delayed
Börse Stuttgart	4YA	Delayed
Boerse Muenchen	4YA	Real-time

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-29	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-15	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-04-29	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-15	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
23-11-07	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
23-10-27	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-27	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-09	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
22-12-23	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
22-12-14	Twitter to shut down newsletter product Revue next year	RE
22-12-05	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
22-10-05	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

Klarsen Stock Börse Stuttgart

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news: Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Price Extremes

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Quotes

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

10-06	Klarsen : Assemblée générale – 29 Septembre 2026
09-08	Klarsen : calendrier de communication
09-08	Klarsen : ALKLA – Klarsen fait évoluer son calendrier de communication financière et rappelle la tenue de ses Assemblées Générales des 29 septembre et 8 octobre 2026 – 08 Septembre 2026
08-27	Klarsen : ALKLA – Présentation webinaire du 27/08/2026 – Support
08-27	Klarsen : Assemblée générale – 29 Septembre 2026

1 week	+16.63%
Current month	+9.06%
1 month	-24.32%
6 months	-34.05%
Current year	-34.36%

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	2008-06-30
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	2012-12-31

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	2010-06-13
Gérard Parrou BRD	Director/Board Member	74	2014-06-26
Frédéric Bartoli BRD	Director/Board Member	-	2011-03-22

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	0.00%	+9.06%	-26.13%	-84.26%	2.34M
IBM	+2.77%	+0.44%	-21.71%	+59.55%	208B
SALESFORCE, INC.	+1.44%	-3.76%	-5.25%	+9.86%	185B
CLOUDFLARE, INC.	-0.31%	-2.60%	+55.40%	+446.59%	122B
SNOWFLAKE INC.	+3.17%	+0.41%	+37.24%	+114.69%	117B
ACCENTURE PLC	+5.96%	-1.86%	-17.64%	-33.26%	117B
TATA CONSULTANCY SERVICES LTD.	-0.21%	+0.05%	-31.42%	-42.67%	77.81B
RELX PLC	-0.15%	+3.39%	-24.21%	-9.36%	59.71B
COREWEAVE, INC.	-7.77%	-7.89%	-41.72%	-	48.78B
FUJITSU LIMITED	+2.45%	+3.86%	+7.64%	+138.35%	45.27B
Average	+1.72%	+0.10%	-6.78%	+66.61%	108.97B
Weighted average by Cap.	+2.02%	-0.80%	-2.03%	+86.56%

	2023	2024
Net sales	5.03M 5.63M 4.69M 4.26M 8.01M 545M 8.09M 56.29M 22.02M 277M 21.13M 20.67M 891M	6.31M 7.07M 5.89M 5.35M 10.06M 684M 10.16M 70.68M 27.65M 348M 26.53M 25.96M 1.12B
Net income	2.75M 3.08M 2.57M 2.33M 4.39M 298M 4.43M 30.81M 12.05M 152M 11.57M 11.31M 488M	-47.76K -53.49K -44.56K -40.48K -76.17K -5.18M -76.91K -535K -209K -2.63M -201K -196K -8.47M
Net Debt	-634K -710K -592K -538K -1.01M -68.81M -1.02M -7.11M -2.78M -34.97M -2.67M -2.61M -112M	1.08M 1.21M 1.01M 916K 1.72M 117M 1.74M 12.1M 4.73M 59.56M 4.54M 4.45M 192M

1 week	0.48	0.65
1 month	0.48	0.81
3 years	0.21	3.55
5 years	0.21	3.86